Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis

Affiliations

• ¹ Department of Pediatrics, Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA.
• ² Pediatric Biostatistics Core, Department of Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA.
• ³ Alberta Children's Hospital, Calgary, Alberta, Canada.
• ⁴ Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, New York, USA.
• ⁵ Children's National Hospital, Washington, DC, USA.
• ⁶ Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
• ⁷ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
• ⁸ Georgia Comprehensive Sickle Cell Center at Grady Health System, Emory University School of Medicine, Atlanta, Georgia, USA.
• ⁹ Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
• ¹⁰ Section of Pediatric Hematology/Oncology/BMT, Yale School of Medicine, New Haven, Connecticut, USA.